Satisfaction with social connectedness as a predictor for positive and negative symptoms of psychosis: A PHAMOUS study.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
12 2021
Historique:
received: 02 11 2020
revised: 02 10 2021
accepted: 03 10 2021
pubmed: 16 10 2021
medline: 26 3 2022
entrez: 15 10 2021
Statut: ppublish

Résumé

This study examines satisfaction with social connectedness (SSC) as predictor of positive and negative symptoms in people with a psychotic disorder. Data from the Pharmacotherapy Monitoring and Outcome Survey (PHAMOUS) was used from patients assessed between 2014 and 2019, diagnosed with a psychotic disorder (N = 2109). Items about social connectedness of the Manchester short assessment of Quality of Life (ManSA) were used to measure SSC. Linear mixed models were used to estimate the association of SSC with the Positive and Negative Syndrome Scale (PANSS) after one and two years against α = 0.01. Analyses were adjusted for symptoms, time since onset, gender and age. Additionally, fluctuation of positive and negative symptom scores over time was estimated. The mean duration of illness of the sample was 18.8 years (SD 10.7) with >65% showing only small variation in positive and negative symptoms over a two to five-year time period. After adjustment for covariates, SSC showed to be negatively associated with positive symptoms after one year (β = -0.47, p < 0.001, 95% CI = -0.70, -025) and two years (β = -0.59, p < 0.001, 95% CI = -0.88, -0.30), and for negative symptoms after one year (β = -0.52, p < 0.001, 95% CI = -0.77, -0.27). The prediction of negative symptoms was not significant at two years. This research indicates that interventions on SSC might positively impact mental health for people with psychosis. SSC is a small and robust predictor of future levels of positive symptoms. Negative symptoms could be predicted by SSC at one year.

Identifiants

pubmed: 34653741
pii: S0920-9964(21)00400-X
doi: 10.1016/j.schres.2021.10.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-127

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Jelle Sjoerd Vogel (JS)

Lentis Psychiatric Institute, Hereweg 80, 9725 AG Groningen, the Netherlands; University of Groningen, Faculty of Behavioral and Social Sciences, Grote Kruisstraat 2/1, 9712 TS Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, P.O. 30.001, 9700 RB, Groningen, the Netherlands; GGZ Drenthe Mental Health Institute, Department of Psychotic Disorders, Dennenweg 9, 9404 LA Assen, the Netherlands. Electronic address: js.vogel@lentis.nl.

Jojanneke Bruins (J)

Lentis Psychiatric Institute, Hereweg 80, 9725 AG Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, P.O. 30.001, 9700 RB, Groningen, the Netherlands. Electronic address: j.bruins@lentis.nl.

Steven de Jong (S)

Lentis Psychiatric Institute, Hereweg 80, 9725 AG Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, P.O. 30.001, 9700 RB, Groningen, the Netherlands. Electronic address: steven.dejong@lentis.nl.

Henderikus Knegtering (H)

Lentis Psychiatric Institute, Hereweg 80, 9725 AG Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, P.O. 30.001, 9700 RB, Groningen, the Netherlands. Electronic address: h.knegtering@lentis.nl.

Agna A Bartels-Velthuis (AA)

Lentis Psychiatric Institute, Hereweg 80, 9725 AG Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, P.O. 30.001, 9700 RB, Groningen, the Netherlands. Electronic address: a.bartels@lentis.nl.

Richard Bruggeman (R)

University of Groningen, Faculty of Behavioral and Social Sciences, Grote Kruisstraat 2/1, 9712 TS Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, P.O. 30.001, 9700 RB, Groningen, the Netherlands. Electronic address: r.bruggeman@umcg.nl.

Frederike Jörg (F)

University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, P.O. 30.001, 9700 RB, Groningen, the Netherlands; GGZ Friesland Mental Health Institute, Department of Research and Education, Sixmastraat 2, 8932 PA Leeuwarden, the Netherlands. Electronic address: frederike.jorg@ggzfriesland.nl.

Marieke G H M Pijnenborg (MGHM)

University of Groningen, Faculty of Behavioral and Social Sciences, Grote Kruisstraat 2/1, 9712 TS Groningen, the Netherlands; GGZ Drenthe Mental Health Institute, Department of Psychotic Disorders, Dennenweg 9, 9404 LA Assen, the Netherlands. Electronic address: marieke.pijnenborg@ggzdrenthe.nl.

Wim Veling (W)

University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Psychosis Department, Hanzeplein 1 (CC60), 9713 GZ, Groningen, the Netherlands. Electronic address: w.veling@umcg.nl.

Ellen Visser (E)

University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, P.O. 30.001, 9700 RB, Groningen, the Netherlands. Electronic address: e.visser03@umcg.nl.

Mark van der Gaag (M)

VU University Amsterdam, Department of Clinical Psychology, Van der Boechorststraat 1, 1081 BR Amsterdam, the Netherlands; Amsterdam Public Mental Health Research Institute, Van der Boechorststraat 1, 1081 BR Amsterdam, the Netherlands; Parnassia Psychiatric Institute, Department of Psychosis Research, Zoutkeetsingel 40, 2512 HN The Hague, the Netherlands.

Stynke Castelein (S)

Lentis Psychiatric Institute, Hereweg 80, 9725 AG Groningen, the Netherlands; University of Groningen, Faculty of Behavioral and Social Sciences, Grote Kruisstraat 2/1, 9712 TS Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, P.O. 30.001, 9700 RB, Groningen, the Netherlands. Electronic address: s.castelein@lentis.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH